ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 602,94
0,41%
Dow Jones
38 778,10
0,49%
DAX
18 114,46
0,23%
Brent Oil
83,675
-0,27%
Bitcoin
65 143,54
-2,02%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Cipher Pharmaceuticals Inc (CPH)

  7. Cipher Pharmaceuticals Inc (CPH) Actualités

CPH

Cipher Pharmaceuticals (CPH)

Cipher Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:CPH
DateHeureSourceTitreSymboleSociété
14/06/202418h46PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of ShareholdersTSX:CPHCipher Pharmaceuticals Inc
09/05/202423h00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter 2024 ResultsTSX:CPHCipher Pharmaceuticals Inc
03/05/202413h05PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
14/03/202422h00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 ResultsTSX:CPHCipher Pharmaceuticals Inc
08/03/202413h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
29/01/202418h56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Sharesof this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202418h56AllPennyStocks.comWill Uplisting Be the Catalyst to Send Shares of this Pharma Company Higher?TSX:CPHCipher Pharmaceuticals Inc
29/01/202413h15PR Newswire (Canada)Cipher Pharmaceuticals Announces the Commencement of OTCQX TradingTSX:CPHCipher Pharmaceuticals Inc
24/11/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Change of AuditorTSX:CPHCipher Pharmaceuticals Inc
15/11/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Normal Course Issuer BidTSX:CPHCipher Pharmaceuticals Inc
09/11/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Sales & Earnings Growth in Q3 2023TSX:CPHCipher Pharmaceuticals Inc
27/10/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q3 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
12/10/202315h57PR Newswire (Canada)Cipher Pharmaceuticals Announces Final Results of Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
03/10/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Provides Reminder of the Upcoming Expiration of its Substantial Issuer BidTSX:CPHCipher Pharmaceuticals Inc
05/09/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Intention to Commence Substantial Issuer Bid, Aggregate Price up to $6 Million Canadian DollarsTSX:CPHCipher Pharmaceuticals Inc
10/08/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Releases Q2 2023 Results, Announces Launch of Epuris in MexicoTSX:CPHCipher Pharmaceuticals Inc
28/07/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
05/07/202313h00PR Newswire (Canada)Cipher Partner, Moberg Pharma Announces Approval for MOB-015 in the European UnionTSX:CPHCipher Pharmaceuticals Inc
11/05/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Reports First Quarter Results, Highlighted by Record Cash Per Share and Strong Financial FlexibilityTSX:CPHCipher Pharmaceuticals Inc
04/05/202323h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
16/03/202322h00PR Newswire (Canada)Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
10/03/202323h30PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q4 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
01/03/202313h00PR Newswire (Canada)Cipher Pharmaceuticals Announces Closing of New US$35 Million Credit FacilityTSX:CPHCipher Pharmaceuticals Inc
11/11/202200h30PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per ShareTSX:CPHCipher Pharmaceuticals Inc
26/10/202213h00PR Newswire (Canada)CIPHER PHARMACEUTICALS SCHEDULES Q3 2022 EARNINGS RELEASE AND CONFERENCE CALLTSX:CPHCipher Pharmaceuticals Inc
11/08/202223h45PR Newswire (Canada)Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFOTSX:CPHCipher Pharmaceuticals Inc
11/08/202223h01PR Newswire (Canada)Cipher Pharmaceuticals Reports Second Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
05/08/202213h00PR Newswire (Canada)Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference CallTSX:CPHCipher Pharmaceuticals Inc
22/06/202223h01PR Newswire (Canada)Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John MullTSX:CPHCipher Pharmaceuticals Inc
12/05/202223h00PR Newswire (Canada)Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial ResultsTSX:CPHCipher Pharmaceuticals Inc
 Showing the most relevant articles for your search:TSX:CPH

Dernières Valeurs Consultées

NYSE
ABB
ABB
NASDAQ
EVOK
Evoke Pharma
LSE
SJ45
Tower B.f 63 S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés